News on MLO Products%2C Incorporated. from BioPortfolio.com http://www.BioPortfolio.com Consolidated MLO Products%2C Incorporated. news from BioPortfolio.com Tue, 09 Feb 2010 00:33:50 GMT en Stock Hunter Is Hot!! Sign Up Today!! GETA,GOVX,NPWZ,VHGI,RDBO,SHMNhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032004&HITNO=0&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032004&THISHREF=http://c.moreover.com/click/here.pl%3fz2534464898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032004&HITNO=0&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032004&THISHREF=http://c.moreover.com/click/here.pl%3fz2534464898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Treck TCP/IP 6.0 Releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031181&HITNO=1&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031181&THISHREF=http://c.moreover.com/click/here.pl%3fz2534045571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031181&HITNO=1&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031181&THISHREF=http://c.moreover.com/click/here.pl%3fz2534045571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029666&HITNO=2&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029666&THISHREF=http://c.moreover.com/click/here.pl%3fz2533227500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029666&HITNO=2&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029666&THISHREF=http://c.moreover.com/click/here.pl%3fz2533227500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029639&HITNO=3&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029639&THISHREF=http://c.moreover.com/click/here.pl%3fz2533217390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029639&HITNO=3&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029639&THISHREF=http://c.moreover.com/click/here.pl%3fz2533217390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031630&HITNO=4&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031630&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031630&HITNO=4&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031630&THISHREF=http://c.moreover.com/click/here.pl%3fz2534281602%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031575&HITNO=5&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031575&THISHREF=http://c.moreover.com/click/here.pl%3fz2534268838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031575&HITNO=5&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031575&THISHREF=http://c.moreover.com/click/here.pl%3fz2534268838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Treck Releases High Performance TCP/IP Stack Implementation for the Xilinx Spartan-6 FPGA Embedded Platformhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031177&HITNO=6&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031177&THISHREF=http://c.moreover.com/click/here.pl%3fz2534044088%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031177&HITNO=6&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031177&THISHREF=http://c.moreover.com/click/here.pl%3fz2534044088%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: FDA Tough on Cell Therapeutics' Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030969&HITNO=7&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030969&THISHREF=http://c.moreover.com/click/here.pl%3fz2533919865%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030969&HITNO=7&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030969&THISHREF=http://c.moreover.com/click/here.pl%3fz2533919865%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTheStreet.com: FDA Tough on Cell Therapeutics' Cancer Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030472&HITNO=8&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030472&THISHREF=http://c.moreover.com/click/here.pl%3fz2533646174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030472&HITNO=8&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030472&THISHREF=http://c.moreover.com/click/here.pl%3fz2533646174%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTheStreet.com: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030110&HITNO=9&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030110&THISHREF=http://c.moreover.com/click/here.pl%3fz2533446623%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030110&HITNO=9&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030110&THISHREF=http://c.moreover.com/click/here.pl%3fz2533446623%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029380&HITNO=10&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029380&THISHREF=http://c.moreover.com/click/here.pl%3fz2533116751%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029380&HITNO=10&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029380&THISHREF=http://c.moreover.com/click/here.pl%3fz2533116751%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon Equityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028674&HITNO=11&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028674&THISHREF=http://c.moreover.com/click/here.pl%3fz2532813178%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028674&HITNO=11&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028674&THISHREF=http://c.moreover.com/click/here.pl%3fz2532813178%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon Equityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028647&HITNO=12&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028647&THISHREF=http://c.moreover.com/click/here.pl%3fz2532800640%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028647&HITNO=12&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028647&THISHREF=http://c.moreover.com/click/here.pl%3fz2532800640%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon Equityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028638&HITNO=13&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028638&THISHREF=http://c.moreover.com/click/here.pl%3fz2532795554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028638&HITNO=13&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028638&THISHREF=http://c.moreover.com/click/here.pl%3fz2532795554%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Pharmaceutical Stock Alert Arena Pharmaceuticals Issued by Beacon Equityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028534&HITNO=14&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028534&THISHREF=http://c.moreover.com/click/here.pl%3fz2532750133%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028534&HITNO=14&MSIZE=837&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MLO%20Products,%20Incorporated.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028534&THISHREF=http://c.moreover.com/click/here.pl%3fz2532750133%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobeNewswire via Yahoo!: